Acuta Capital Partners’s Immunomedics Inc IMMU Stock Holding History

Acuta Capital Partners’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-667,500	Closed	-$9.33M	–	90
2017 Q3	$9.33M	Buy	+667,500	New	+$6.65M	1.67%	13
2017 Q1	–	Sell	-100,000	Closed	-$367K	–	81
2016 Q4	$367K	Buy	100,000 +41,400	+71%	+$122K	0.14%	42
2016 Q3	$190K	Hold	58,600	–	–	0.07%	60
2016 Q2	$136K	Buy	+58,600	New	+$196K	0.07%	59

Acuta Capital Partners's IMMU Position: Q4 2020 in Review

Acuta Capital Partners sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 511,500 shares — an estimated $43.5M sold.

Acuta Capital Partners first reported a position in IMMU in Q3 2015 and held it in 19 quarters. The position peaked at $112M in Q2 2018. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Acuta Capital Partners reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Acuta Capital Partners sold 511,500 Immunomedics Inc shares in Q4 2020, an estimated $43.5M.
Acuta Capital Partners first reported a position in Immunomedics Inc in Q3 2015 and held it in 19 quarters.
Acuta Capital Partners's Immunomedics Inc position peaked at $112M in Q2 2018.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Acuta Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.